Abstract
Over the last decade, transcatheter aortic valve implantation (TAVI) has gained widespread acceptance for the treatment of high surgical risk or inoperable patients with severe aortic stenosis. Spurred on by initial success and an ever-growing body of supporting data, TAVI has undergone rapid technological advancements in recent years with a focus on procedural simplification and limiting complications associated with the early devices. In this article, we provide a brief overview of the past, current and newer devices for transfemoral (TF) TAVI and their post-procedural outcomes.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Aortic Valve / physiopathology
-
Aortic Valve Stenosis / diagnosis
-
Aortic Valve Stenosis / physiopathology
-
Aortic Valve Stenosis / surgery
-
Aortic Valve Stenosis / therapy*
-
Balloon Valvuloplasty
-
Cardiac Catheterization / adverse effects
-
Cardiac Catheterization / instrumentation*
-
Cardiac Catheterization / methods
-
Catheterization, Peripheral* / methods
-
Femoral Artery*
-
Heart Valve Prosthesis Implantation / adverse effects
-
Heart Valve Prosthesis Implantation / instrumentation*
-
Heart Valve Prosthesis Implantation / methods
-
Heart Valve Prosthesis*
-
Humans
-
Patient Selection
-
Prosthesis Design
-
Risk Assessment
-
Risk Factors
-
Treatment Outcome